Transition Therapeutics Inc. (TTHI) was a big mover last session with shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month’s volatile price range of $6.02 to $6.77.
This biopharmaceutical company has not seen any estimate revision over the last 30 days. The Zacks Consensus Estimate also remained unchanged over the same period.Friday’s rally is encouraging though, so make sure to keep a close watch on this stock in the near future.
Transition Therapeutics currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the biomedical industry include Alexion Pharmaceuticals, Inc. (ALXN), Biogen Idec Inc. (BIIB) and Actelion Ltd. (ALIOF). While Alexion sports a Zacks Rank #1 (Strong Buy), Biogen Idec and Actelion carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
TRANSITION THERAPEUTICS ORD (TTHI): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading